Clinical bottom line
The maternal microbiome, encompassing gut and endometrial microbial communities, plays a significant role in pregnancy outcomes, influencing risks of gestational diabetes, early pregnancy loss, and fetal development. Emerging evidence suggests that maternal nutrition and antibiotic exposure can modulate the microbiome, with downstream effects on maternal and neonatal health. While mechanistic insights are growing, clinical application remains limited by heterogeneity in study designs and populations. Integrating microbiome considerations into prenatal care may improve risk stratification and inform interventions to optimize pregnancy outcomes (Torres-Torres et al., 2024; Odendaal et al., 2024; Muglia et al., 2022).
What the evidence shows
Torres-Torres et al. (2024) detail the cellular and molecular pathophysiology of gestational diabetes mellitus (GDM), highlighting how alterations in the maternal gut microbiome contribute to metabolic dysregulation during pregnancy. Dysbiosis may exacerbate insulin resistance and inflammation, influencing GDM risk and severity.
Odendaal et al. (2024) investigate the endometrial microbiota’s association with early pregnancy loss, finding that imbalances in microbial composition correlate with implantation failure and miscarriage. Their work underscores the potential of microbiome profiling in early pregnancy assessment.
Muglia et al. (2022) provide a broad overview of maternal factors affecting maternal, fetal, and childhood outcomes, emphasizing the microbiome’s role as a modifiable determinant influenced by diet, environment, and medication exposure.
Aulia et al. (2025) focus on maternal nutrition’s impact on the gut microbiome and fetal outcomes, suggesting that targeted nutritional interventions may beneficially modulate microbial communities to support healthy fetal growth.
Powell et al. (2026) report from a pilot randomized controlled trial that short-term fluoride supplementation during pregnancy alters the maternal microbiome without adverse effects on pregnancy or neonatal outcomes, demonstrating the feasibility of microbiome-targeted interventions.
Caveats and uncertainty
Microbiome studies often face challenges including small sample sizes, variability in sequencing methods, and confounding factors such as diet and antibiotic use.
Causal relationships between microbiome alterations and adverse pregnancy outcomes remain to be conclusively established.
Optimal timing, composition, and delivery methods for microbiome-modulating interventions are not yet defined.
Long-term effects of microbiome changes during pregnancy on offspring health require further longitudinal research.
Clinical translation is limited by lack of standardized microbiome assessment protocols in obstetric practice.
How this may change practice
Clinicians should recognize the maternal microbiome as an emerging factor influencing pregnancy outcomes and consider its potential when evaluating risk profiles.
Nutritional counseling and judicious antibiotic use during pregnancy may help preserve beneficial microbiota and reduce adverse outcomes.
Future prenatal care may incorporate microbiome profiling to identify women at risk for complications such as GDM or early pregnancy loss.
Microbiome-targeted therapies, including probiotics or dietary modifications, could become adjunctive strategies pending further evidence.
Multidisciplinary collaboration between obstetricians, nutritionists, and microbiologists will be important to translate research into practice.
Ongoing clinical trials and larger cohort studies will clarify the role of microbiome modulation in improving maternal-fetal health.